Ginsenoside-Rb2 and 20(S)-Ginsenoside-Rg3 from Korean Red Ginseng Prevent Rotavirus Infection in Newborn Mice |
Yang, Hui
(Department of Microbiology, College of Medicine, Konyang University)
Oh, Kwang-Hoon (Department of Physical Education, College of Education, Kongju National University) Kim, Hyun Jin (Department of Microbiology, College of Medicine, Konyang University) Cho, Young Ho (Department of Pharmaceutics & Biotechnology, College of Medical Engineering, Konyang University) Yoo, Yung Choon (Department of Microbiology, College of Medicine, Konyang University) |
1 | Desselberger U. 2014. Rotaviruses. Virus Res. 190: 75-96. DOI |
2 | Parashar UD, Burton A, Lanata C, Boschi-Pinto C, Shibuya K, Steele D, et al. 2009. Global mortality associated with rotavirus disease among children in 2004. J. Infect. Dis. 200: S9-S15. DOI |
3 | Jiang V, Jiang B, Tate J, Parashar UD, Patel MM. 2010. Performance of rotavirus vaccines in developed and developing countries. Hum. Vaccin. 6: 532-542. DOI |
4 | Song X, Hu S. 2009. Adjuvant activities of saponins from traditional Chinese medicinal herbs. Vaccine 27: 4883-4890. DOI |
5 | Sun HK, Xie Y, Ye YP. 2009. Advances in saponin-based adjuvants. Vaccine 13: 1787-1796. |
6 | Kirk DD, Rempel R, Pinkhasov J, Walmsley AM. 2004. Application of Quillaja saponaria extracts as oral adjuvants for plant-made vaccines. Expert Opin. Biol. Ther. 4: 947-958. DOI |
7 | Pickering RJ, Smith SD, Strugnell RA, Wesselingh SL, Webster DE. 2006. Crude saponins improve the immune response to an oral plant-made measles vaccine. Vaccine 24: 144-150. DOI |
8 | Park D, Bae DK, Jeon JH, Lee N, Yang G, Yang YH, et al. 2011. Immunopotentiation and antitumor effects of a ginsenoside Rg-fortified red ginseng preparation in mice bearing H460 lung cancer cells. Environ. Toxicol. Pharmacol. 31: 397-405. DOI |
9 | Yu JL, Dou DQ, Chen XH, Yang HZ, Guo N, Cheng GF. 2005. Protopanaxatriol-type ginsenosides differentially modulate type 1 and type 2 cytokines production from murine splenocytes. Planta Med. 71: 202-207. DOI |
10 | Dong H, Bai LP, Wong VK, Zhou H, Wang JR, Liu Y, et al. 2011. The in vitro structure-related anti-cancer activity of ginsenosides and their derivatives. Molecules 9: 10619-10930. |
11 | Mochizuki M, Yoo YC, Matsuzawa K, Sato K, Saiki I, Tono-oka S, et al. 1995. Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng. Biol. Pharm. Bull. 18: 1197-1202. |
12 | Musende AG, Eberding A, Wood CA, Adomat H, Fazli L, Hurtado-Coll A, et al. 2012. A novel oral dosage formulation of the ginsenoside aglycone protopanaxadiol exhibits therapeutic activity against a hormone-insensitive model of prostate cancer. Anticancer Drugs 23: 543-552. DOI |
13 | Sato K, Mochizuki M, Saiki I, Yoo YC, Samukawa K, Azuma I. 1994. Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside-Rb2. Biol. Pharm. Bull. 17: 635-639. DOI |
14 | Cho JY, Kim AR, Yoo ES, Baik KU, Park MK. 2002. Ginsenosides from Panax ginseng differentially regulate lymphocyte proliferation. Planta Med. 68: 497-500. DOI |
15 | Kim JY, Kim HJ, Kim HJ. 2011. Effect of oral administration of Korean red ginseng on influenza A (H1N1). J. Ginseng Res. 35: 104-110. DOI |
16 | Lee MH, Lee BH, Jung JY, Cheon DS, Kim KT, Choi C. 2011. Antiviral effect of Korean red ginseng extract and ginsenosides on murine norovirus and feline calicivirus as surrogates for human norovirus. J. Ginseng Res. 35: 429-435. DOI |
17 | Lee KT, Jung TW, Lee HJ, Kim SG, Shin YS, Whang WK. 2011. The antidiabetic effect of ginsenoside Rb2 via activation of AMPK. Arch. Pharm. Res. 34: 1201-1208. DOI |
18 | Yoo YC, Lee J, Park SR, Nam KY, Cho YH, Choi JE. 2013. Protective effect of ginsenoside-Rb2 from Korean red ginseng on the lethal infection haemagglutinating virus of Japan in mice. J. Ginseng Res. 37: 80-86. DOI |
19 | Fukushima A, Yoo YC, Yoshomatsu K, Matsuzawa K, Tamura M, Tono-oka S, et al. 1996. Effect of MDP-Lys(L18) as a mucosal immunoadjuvant on protection of mucosal infections by Sendai virus and rotavirus. Vaccine 14: 485-491. DOI |
20 | Samukawa K, Yamashita H, Matsuda H, Kubo M. 1995. Simultaneous analysis of saponins in Ginseng Radix by high performance liquid chromatography. Chem. Pharm. Bull. 43: 437-141. DOI |
21 | Du XF, Jiang CZ, Wu CF, Won EK, Choung SY. 2008. Synergistic immunostimulating activity of pidotimod and red ginseng acidic polysaccharide against cyclophosphamide-induced immunosuppression. Arch. Pharm. Res. 31: 1153-1159. DOI |
22 | Bomford R, Stapleton M, Winsor S, Beesley JE, Jessup EA, Price KR, et al. 1992. Adjuvanticity and ISCOM formation by structurally diverse saponins. Vaccine 10: 572-577. |
23 | Yuki Y, Kiyono H. 2003. New generation of mucosal adjuvants for the induction of protective immunity. Rev. Med. Virol. 13: 293-310. DOI |
24 | Sun Y, Guo M, Feng Y, Zheng H, Lei P, Ma X, et al. 2016. Effect of ginseng polysaccharides on NK cell cytotoxicity in immunosuppressed mice. Exp. Ther. Med. 12: 3773-3777 DOI |
25 | Yoo DG, Kim MC, P ark MK, Song JM, Quan FS, P ark KM, et al. 2012. Protective effect of Korean red ginseng extract on the infections by H1N1 and H3N2 influenza viruses in mice. J. Med. Food 15: 855-862. DOI |